To explore the value of brain MRI in Wilson's disease (WD) in relating neurological symptoms with clinical manifestations of the disease, a retrospective analysis of 76 WD patients with neurological symptoms was performed. Patients' neurological symptoms, brain MRI features, and laboratory findings were noted. MRI was abnormal in 89.5% of patients. The lenticular nucleus was the most commonly lesioned site, being affected in 75% of patients, followed by the caudate nucleus (lesioned in 30.9% of patients), pons (30.9%), thalamus (29.4%), midbrain (20.6%), cerebral cortex and white matter (5.9% of patients in each case), and cerebellum and hippocampus (4.4% in each case). Brain atrophy was also relatively common, occurring in 31.6% of subjects. We also determined that the sensitivity of T2 was 89.7%, while that of T1 and FLAIR were both 76.5%. 23 patients were scanned without the benefit of contrast enhancement, and of the 8 patients who were scanned with DWI, 6 exhibited hypointensities, while 2 were normal. The 5 patients who underwent susceptibility-weighted imaging (SWI) all showed hypointensities. A longer disease duration appeared to be more prevalent when thalamic abnormalities were observed, and tremor seemed to be correlated with cerebral atrophy. Ataxia was correlated with brainstem, cerebellar, and cerebral cortex lesions. It was determined that the T2 sequence has a higher sensitivity compared to T1 and FLAIR in the detection of brain lesions.
Introduction
Hepatolenticular degeneration (HLD), also known as Wilson's disease (WD), is a rare autosomal recessive condition. Its incidence rate varies from 1/30,000-1/10,0000, while carrier frequency is approximately 1/90, and the disease is known to be more prevalent amongst the Chinese and other Asian populations [1] . The pathogenic gene ATP7B, located at chromosome 13q14.3, encodes for a copper-transporting ATPase that facilitates the combination of copper and a 2 -globulin into ceruloplasmin in liver, a process that is responsible for the elimination of 90% of the copper found in the circulation in normal individuals [2] . In individuals affected by WD, however, impaired copper metabolism and excretion leads to the deposition of redundant free copper in the brain, liver, cornea, kidney and other organs, resulting in organ damage [3] .
WD is typically diagnosed via its various neurologic and hepatic clinical symptoms, biochemical tests for copper, or through the presence of Kayser-Fleischer (K-F) rings in the cornea. Neurologically, WD may manifest with extrapyramidal and pyramidal features, as well as cognitive and psychiatric symptoms. Early diagnosis and intervention for patients with WD are essential, and magnetic resonance imaging (MRI), which possess a level of specificity and sensitivity far superior to that of computed tomography (CT) [4] , can be a particularly important tool in this regard, especially for patients presenting with initial neurological symptoms. Pathological changes in the brain, as revealed by MRI, have been reported to correlate with the severity of the neurological symptoms of WD and, with disease severity in general [5] . However, whether MRI changes can be a useful predictor of disease duration [6] and outcome [7] remains a matter of some debate.
There have been relatively few studies evaluating the sensitivity of various MRI sequences in WD patients. In this study, through the retrospective analysis of 76 WD cases, we aimed to compare the different sensitivities of various MRI sequences (T1, T2, FLAIR, and DWI) in revealing abnormalities in WD, and the association between the MRI features and clinical manifestation. 
Subjects and methods

Inclusion criteria
This was a retrospective study involving WD patients with neurological manifestations, as diagnosed by Department of Neurology of the Second Xiangya Hospital of Central South University and Changde First People's Hospital, between 2011 and 2016. Patient clinical data were first retrieved from the electronic patient record system, following which symptoms classification were extracted from pathographical and physical examination records by a neurologist, while electronic MRI scans were reviewed by a neuroradiologist, who then compared their current findings with those described in the original reports. Uncertainties at this stage were resolved through consultation with a supporting neurologist or neuroradiologist. MRI was performed with a 3.0 T scanner, with the various sequences using the following parameters: T1-repetition time (TR) 2000, echo time (TE) 18, NEX 1, T2-TR 3000, TE 80, NEX 1, FLAIR-TR 8000, TE 125, NEX 1, and DWI-TR 4900, TE 98, NEX 1. MRI slice thickness in all sequences were set at 6.5 or 7.0 mm. After excluding patients whose records did not include complete clinical data or brain MRI scans, and those with only hepatic manifestations, we determined that 76 cases to be suitable for inclusion in this study.
Diagnostic criteria
Diagnoses of WD was performed in accordance with European Association for the Study of the Liver (EASL) Clinical Practice Guidelines: Wilson's disease (2012) [8] and Chinese Medical Association guidelines for the diagnosis and treatment of Wilson's disease (2008). The criteria employed included: the presence of liver disease or extrapyramidal symptoms, low serum ceruloplasmin levels or elevated liver copper levels, the presence of corneal K-F rings, and positive family histories of WD.
Clinical classification
Patients enrolled in this study were divided into one of four categories according to their neurological symptoms: those suffering from tremor, bradykinesia, myotonia, and postural disability were assigned to the ''Parkinsonian syndrome" group; those with torsion dystonia, athetosis, chorea, gait abnormality, and ataxia the ''dyskinesia" group; those with salivation, speech difficulties, dysarthria, and deglutition disorder the ''oromandibular dystonia" group; while those with mental symptoms formed a category on their own.
Statistical analysis
Analysis of the association between categorical data was performed using the chi-square test of R * C table or the Fisher exact test, and the nonparametric U test was used for continuous data.
Only in instances where the P value <0.05 were the data considered to be statistically significant. All statistical analysis was performed using IBM Ò SPSS Ò Statistics 19.0.
Results
Of the 76 patients with neurologic WD enrolled in the study, 45 were male and 31 were female, giving a male:female ratio of 1.45:1 (Fig. 1) . The average age of onset of symptoms was 18.03 ± 8.48 years old, with a range of 7-50 years, and a median age of 16 years. 51.3% of patients were between the ages of 11-20, and only one patient was over the age of 41 (Fig. 2) . There was no significant difference in the age of onset between males and females (P = 0.106). The mean duration of illness was 28.55 ± 46.16 months, with a range of 3 days to 22 years, and more than half of patients exhibited symptoms for <12 months (Fig. 3) . No significant difference was identified between the male and female groups with regards to the duration of illness (P = 0.893).
Clinical manifestations
Neurological symptoms
Neurological symptoms were present in all patients in this study. The most common neurologic manifestations were Parkinsonian syndrome (observed in 38 patients, or 50% of the cases here). Within this group, 29 (or 38.2%) patients suffered from tremor, 16 (21.1%) from bradykinesia, 8 (10.5%) from postural disability, while 3 (3.9%) exhibited myotonia. Within the dyskinesia group (20 patients, or 26.3%): 11 (14.5%) were afflicted with athetosis, 9 (11.8%) with ataxia, 7 (9.2%) with gait abnormalities, and 2 (2.6%) with torsion dystonia and chorea. For patients classified as suffering from oromandibular dystonia (of which there were 46, comprising 60.5% of the sample population), 43 (56.6%) had speech male 59% female 41% male-to-female ratio disorders; 21 (27.6%) had salivation issues; while 7 (9.2%) exhibited difficulties with deglutition. 17 patients (22.4% of cases) were diagnosed with having mental symptoms. In addition, epilepsy was seen in 6, or 7.9%, of patients (Fig. 4) .
Other clinical features
Of the 76 patients, 41 (53.9%) suffered from hepatic disease, 5 (6.6%) from renal injury, 7 (9.2%) from osteoarticular and muscular damage, and 1 (1.3%) from hemolytic anemia. 11 (14.5%) had a positive family history of WD. Corneal K-F rings were identified in 66 patients (86.8%).
Serum ceruloplasmin concentrations (normal: 200-500 mg/L) were tested in all patients. Ceruloplasmin levels were measured to be <80 mg/L in 59 patients (77.6%), and between 80 and 200 mg/L in 14 patients (18.5%). Only 3 patients (3.9%) exhibited serum ceruloplasmin levels >200 mg/L.
Brain MRI
68 patients (89.5%) showed MRI abnormalities, while the remaining 8 patients with normal brain MRI were nonetheless affected by neurological symptoms. While there was no significant difference in the age of disease onset between patients with abnormal and normal MRI (18.54 ± 8.68 vs 13.63 ± 4.87, P > 0.05), disease duration in MRI-abnormal patients was significant longer than that in patients with who were MRI-normal (31.37 ± 48.02 vs 4.57 ± 4.55, P < 0.05; Fig. 5 ).
The most commonly affected site was the lenticular nucleus, with abnormalities observed in 51 patients (75%), followed by the brain stem (affected in 25 patients or 36.8% of the sample); the pons (21 patients/30.9%), the midbrain (14 patients/20.6%), the caudate nucleus (21 patients/30.9%), the thalamus (20 patients/29.4%), the cerebral cortex and white matter (4 patients, or 5.9% of the sample in each case), and the hippocampus and cerebellum (3 patients/4.4% for each). 24 patients (35.3%) exhibited brain atrophy, with 19 exhibiting atrophy in the cerebrum, 6 in the cerebellum and 3 in the brain stem (Figs. 6 and 7) .
In 68 MRI-abnormal patients, 52 (76.5%) showed changes in the T1 sequence, while 61 (89.7%) had T2 abnormalities. T1 and/or T2 abnormalities were observed in 63 patients (92.6%), with typical T1 hypointensities and T2 hyperintensities observed in 44 patients (64.7%); Only 1 patient was found to be T1-hyperintense and T2-hypointense; In 11 patients with T1 isointense, T2 abnormalities were observed hyperintense in 7 and hypointense in 4; 2 patients with T2 isointense were all exhibited T1 hyperintense; 2 patients showed the same hyperintense or hypointense on T1 and T2 for each; Mixed signal on T1 and T2 was observed in 1 patient.
52 patients (76.5%) showed abnormalities on the FLAIR sequence: hyperintensities were seen in 46 cases (67.6%), hypointensities in 4 cases (5.9%), and mixed signals in 2 cases (2.9%). Interestingly, 1 patient was FLAIR-hyperintense, but T1-and T2-normal. Gadolinium enhancement did not appear to improve scan quality in the 23 patients who underwent the process. In the 8 patients in which diffusion-weighted imaging (DWI) was performed, 6 were found to be hypointense, and 2 were isointense. In the 5 patients who underwent susceptibilityweighted imaging (SWI), scans found all to be hypointense. 4 patients with cerebral atrophy exhibited no observable MRI abnormalities (Fig. 8 ).
Association between clinical features and brain MRI 3.3.1. Association between age of onset and brain MRI findings
In our sample population, the age of onset was clustered around the age range of 10-30 years, with the majority of cases (51.3%) occurring between the age of 11-20. Few patients developed the disease when they were over 40 years of age, and only a single individual developed WD at age 50, exhibiting no abnormalities according to MRI and manifesting only brain atrophy. Amongst Table 1 ).
Association between illness duration and brain MRI characteristics
Patients were hospitalized in department of neurology, with most already suffering from neurological symptoms. 44 patients (57.9% of the sample) had been diagnosed within the past year, underscoring the importance of neurological symptoms for early diagnosis in WD. Patients who had lived with the disease for over a year all had different degrees of abnormality on brain MRI scans in this study. Statistical analysis indicated that the development of thalamic lesions was correlated with the duration of illness (v 2 = 9.247, P = 0.026; Table 2 ). of the MRI lesion sites and athetosis, gait abnormality, torsion dystonia, or chorea. We also found no obvious association between oromandibular dystonia, mental symptoms, and epilepsy with MRI abnormalities (Table 3 ).
Discussion
Wilson's disease is one of the few hereditary conditions that respond well to treatment, with a regular regimen of de- coppering agents frequently leading to the significant improvement of symptoms [9] . Early diagnosis and treatment is thus crucial for WD. WD occurs more frequently in men than in women. The age of WD onset for most occurs between 5 and 35 years, which may reflect the potential copper storage capacity of the liver [10] . A series of studies showed that the youngest age of WD was 3 and the oldest was 80 years [11, 12] . Taly et al. reported that among 282 WD patients, the age of onset was <10 years for 26% of patients, between 10 and 20 for 54.8% of patients, between 20 and 30 for 11.9% of patients, between 30 and 40 for 5.9% and >40 years in 1.4% of cases, suggesting that WD can present over a wide range of ages [13] . In the present study, the youngest patient was 7 years of age, while the oldest was 50. The majority of patients were in the 10-30 age group, with most (39 patients, or 51.3% of the population) being between 11 and 20 years. Only 1 patient with positive corneal K-F ring, in which neurologic deficits could not be identified, was over the age of 50. Thus, it is necessary to take WD into consideration for patients aged 10-30 years with extrapyramidal symptoms. For those patients older than 50 years with extrapyramidal symptoms (or even apparent normality), WD should also be considered to further K-F ring and ceruloplasmin measure.
Most patients in this study exhibited neurological symptoms. The average duration of illness at the time of diagnosis in this study was 28.55 ± 46.16 months, and 44 patients (57.9% of total) had been diagnosed within the last year. Relatively speaking, the diagnostic yield in cases of WD that present with neurological symptoms within early stage (<1 year) is often quite high. Park et al reported that patients with osteoarticular and muscular damage were older than those with neurological symptoms [14] . Our study also revealed that patients with disease durations of over a year all had abnormal MRI manifestations, and that the disease duration of MRI-abnormal patients was significantly longer than that of patients with normal MRI results. These findings suggest that patients with early WD may be free of MRI abnormalities, which in turn highlights the importance of neurological symptoms in forming a timely diagnosis. Regardless, it is clear that MRI abnormalities are a useful index in the assessment of disease course when neurological symptoms are present.
Brain lesions may be present in multiple sites in WD, exhibiting symmetry abnormal signal in bilateral hemisphere mostly [15] . In the present study, we found that the lenticular nucleus was the most commonly affected site, and the hippocampus and cerebellum were the least, a finding that was consistent with a previous report [16] . With regards to the brain stem, lesions were more common in the midbrain and pons. The medulla, however, did not seem to be affected in any of the patients in this study. In the case of the cerebral cortex, lesions of the frontal cortex were the most common, with the parietal and occipital cortex being affected to a lesser extent. It was also seen that two or more sites often contained lesions in the same patient. The white matter was frequently also involved in the frontal, parietal, temporal, and occipital lobes regardless of whether cortex lesions were observed, with the former presenting as a diffuse abnormal signal extending from the frontal to the occipital lobe [17] . In addition to the sites already mentioned, WD lesions could also involve corpus callosum [18] and the conduction tracts, including the corticospinal, red nucleus thalamic, and cerebellopontine tracts [19] . Interestingly, we saw here that 24 patients (31.6% of total) exhibited some degree of brain atrophy, most often in the cerebrum, in contrast with a previous study which suggested that atrophy was not common in WD patients [20] . It is possible that differences in disease progression or duration may have contributed to this discrepancy.
44 of 68 patients exhibited brain MRI manifestations typical of WD, with hypointense T1 and hyperintense T2 signals of symmetrically distributed in the sites that had been found in this study to be commonly affected. These manifestations were due not to paramagnetic deposition of copper ions, but rather the hypertrophy of astrocytes, local cerebral edema, demyelination and cystic changes caused by the excessive deposition of copper ions [21] . The resulting of the enhancement of the paramagnetic properties of copper due to this deposition was the most likely reason for the hyperintense T1 and hypointense, or mixed, T2 signals [22] , 1 patients showed hyperintense T1 and hypointense T2 with a relatively long duration of 3 years in our study, which was consistent with paramagnetic properties of copper deposition. A hyperintense T1 signal had likewise been observed in WD patients with severe combined hepatic dysfunction due to the deposition of manganese ions [23] . The deposition of copper may have an opposite effect on the T2 signal compared with the damage caused cell edema damage, and the mixed T2 signal could reflect the result of this interaction [24] . Research has shown that WD brain MRI appeared enhancement along with the gyrus, suggesting damage to the blood-brain barrier in WD patients [25] . However, in our study, 23 patients underwent enhanced scanning and this failed to reveal any enhancement, with less damage to blood-brain barrier, suggesting that copper ions are more likely to accumulate in nerve cells than in endothelial cells. The present study revealed the T2 sequence to possess the highest degree of sensitivity (89.7%), followed by FLAIR and T1 (76.5% for each), in contrast with a previous study which found FLAIR and T2 to be equally sensitive in detecting WD lesions [7] . There was, however, 1 patient in this study who had a hyperintense FLAIR signal, but who had no abnormalities on T1 and T2. The above perhaps illustrates that a combination of FLAIR and T2 sequences may be required in order to attain the greatest level of sensitivity. In 8 patients underwent DWI, 6 were hypointense on DWI sequence due to the increased diffusion of water molecules, it maybe caused by neuron necrosis and cavernous degeneration rather than inflammation. Also, as extensive hypointense lesions were visible only via SWI, and not when using T2, it has been suggested that SWI may outperform traditional MRI sequences in certain cases [26] . We were unable to corroborate this here, as the 5 patients in this study who exhibited SWI-hypointense signals had T1 or T2 abnormalities as well.
The association between the MRI features characteristic of WD and the disease's clinical manifestations were different in previous studies. While some have hypothesized that WD brain lesions only occurred subsequent to the changes in copper ion metabolism, the early diagnosis of MRI for WD was deficiency [27] . Meanwhile, Sinha et al. have suggested that MRI findings were associated with the disease severity only, and not disease duration [28] . Other research showed that the location of lesions did not correlate with the number of lesions or disease prognosis [7] . We showed here that patients who were between the ages 11-20 at the onset of the disease were liable to form thalamic lesions, while those that were between 21 and 30 years of age were more likely to have cerebellar lesions. Additionally, it was seen that thalamic lesions were likely to be associated with longer disease durations, suggesting that the patients with thalamic lesions on MRI had a younger age of onset and longer duration, thalamic MRI lesions may be highly suggestive of the disease, but whether this was related to the manner in which copper was deposited in the thalamus in these instances will require further research. Additionally, we found associations between tremor and cerebral atrophy, and between ataxia and lesions of the brain stem, cerebellum and cerebral cortex in this study, extending the findings of previous studies which have identified associations between tremor and lesions in the globus pallidus [6] , and between ataxia and focal thalamic lesions [29] . The brain stem and cerebellum were relatively rarely affected, and this study suggests that for patients with ataxia and lesions of brain stem or cerebellum according to MRI, WD should be considered.
Because studies of this ilk have thus far featured only relatively small pools of patients, further research will be needed before any conclusions can be drawn regarding the association between the MRI characteristics in WD patients and disease duration, prognosis, and outcome.
Limitations of study
The current study is limited by its retrospective nature, which, when combined with the relatively large variety of nervous system symptoms being analyzed, confounded our attempts to form correlations between the symptoms exhibited by the patients and the sites of their lesions. Regardless, we were able to identify a role for brainstem and cerebellar lesions in causing ataxia in the patients. Further, not all patients were imaged using every MRI modality analyzed here, thereby limiting our access to DWI and SWI data. Additionally, our R * C analysis determined that the expected frequencies were lower than 5, or even 0 in certain cases. Therefore, despite our use of the Fisher exact test in our analysis, larger sample sizes will be needed to elucidate the relationship between them.
